Viewing Study NCT05281003


Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2025-12-28 @ 2:42 PM
Study NCT ID: NCT05281003
Status: RECRUITING
Last Update Posted: 2023-07-13
First Post: 2022-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module